Conatus Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
CNAT Conatus Pharmaceuticals Inc
AGR Avangrid Inc
OMI Owens & Minor Inc
PSA-U Public Storage
BAC Bank of America Corp
GM General Motors Co
GLW Corning Inc
GILD Gilead Sciences Inc
GG Goldcorp Inc
GEN Genesis Healthcare Inc
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

Conatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease. The Company operates through commercialization and development of pharmaceutical products segment. The Company is engaged in developing emricasan, which is an orally active pan-caspase protease inhibitor for the treatment of patients with chronic liver disease. Emricasan has the potential to interrupt the progression of liver disease and provide treatment options in multiple areas of liver disease. Emricasan is designed to slow or halt the progression of chronic liver disease caused by fibrosis and cirrhosis. Emricasan works by inhibiting caspases, which are a family of related enzymes that plays as modulators of critical cellular functions, including functions that result in apoptosis and inflammation.

Closing Price
$1.88
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.96
Day's Low
1.85
Volume
(Light)
Volume:
352,983

10-day average volume:
493,446
352,983
  • Prev Close
    1.88
  • Today's Open
    1.89
  • Day's Range
    1.85-1.96
  • Avg Vol (10-day)
    493.4K
  • Last (time)
    4:00p ET 02/20/19
  • Last (size)
    190
  • 52-Wk Range
    1.15 - 7.95
    LowHigh
  • (03/09/18 - 12/24/18)
    63.48%
  • 125.5%
  • Market Cap
    56.9M
  • Shares Outstanding
    30.3M
  • -0.61
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 3.4
  • 25.95
  • (% of float 01/31/19)
    10.31

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.